Ponezumab

Ponezumab (PF-04360365) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab can be used in study of Alzheimer's disease.
Read more
€0.00 (tax incl.)
Reference:
HY-P99216
Product Details
HY-P99216

Data sheet

Size
Multiple sizes
Reactivity
EGFR
Application
Neuroscience-Neurodegeneration
CAS
1178862-65-1

Menu

Settings